CAS: 2041073-22-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GNF4877 REF: IN-DA01N18OCAS: 2041073-22-5 | 98% | To inquire | Mon 16 Dec 24 |
 | GNF4877 REF: TM-T11447CAS: 2041073-22-5 | 98.63% - 99.40% | 123.00 €~1,725.00 € | Mon 23 Dec 24 |
 | GNF4877 REF: 3D-RGD07322CAS: 2041073-22-5 | Min. 95% | To inquire | Mon 27 Jan 25 |
Ref: IN-DA01N18O
| 10mg | 168.00 € | ||
| 25mg | 313.00 € | ||
| 50mg | 489.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
GNF4877
CAS:2041073-22-5
GNF4877 inhibits DYRK1A/GSK3β (IC50: 6/16 nM), blocks NFATc export, and boosts β-cell growth.
Formula:
C25H27FN6O4
Purity:
98.63% - 99.40%
Color and Shape:
Solid
Molecular weight:
494.52
Ref: TM-T11447
| 1mg | 123.00 € | ||
| 5mg | 291.00 € | ||
| 10mg | 507.00 € | ||
| 25mg | 921.00 € | ||
| 50mg | 1,278.00 € | ||
| 100mg | 1,725.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
GNF4877
CAS:2041073-22-5
GNF4877 is an oral medication that has been shown to enhance the ability of insulin-producing …
Formula:
C25H27FN6O4
Purity:
Min. 95%
Molecular weight:
494.5 g/mol
Ref: 3D-RGD07322
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
